Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.

B-cells play a pivotal role in several autoimmune diseases, including patients with immune-mediated neurological disorders (PIMND), such as neuromyelitis optica (NMO), multiple sclerosis (MS), and myasthenia gravis (MG). Targeting B-cells has been an effective approach in ameliorating both central a...

Full description

Bibliographic Details
Main Authors: Anza B Memon, Adil Javed, Christina Caon, Shitiz Srivastawa, Fen Bao, Evanthia Bernitsas, Jessica Chorostecki, Alexandros Tselis, Navid Seraji-Bozorgzad, Omar Khan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5757948?pdf=render

Internet

http://europepmc.org/articles/PMC5757948?pdf=render

Similar Items